Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Project Optimus: Is the US Food and Drug Administration Waiving Dose Optimization for Orphan Drugs?
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Project Optimus: Is the US Food and Drug Administration Waiving Dose Optimization for Orphan Drugs?
Project Optimus: Is the US Food and Drug Administration Waiving Dose Optimization for Orphan Drugs? JAMA Oncol. 2023 Nov 01; 9(11):1489-1490.
View in:
PubMed
subject areas
Drug Approval
Humans
Orphan Drug Production
Product Surveillance, Postmarketing
United States
United States Food and Drug Administration
authors with profiles
Mark J. Ratain